 |
PDBsum entry 4g27
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Metal transport/calcium binding protein
|
PDB id
|
|
|
|
4g27
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Identification of the functional binding pocket for compounds targeting small-Conductance ca²⁺-Activated potassium channels.
|
 |
|
Authors
|
 |
M.Zhang,
J.M.Pascal,
M.Schumann,
R.S.Armen,
J.F.Zhang.
|
 |
|
Ref.
|
 |
Nat Commun, 2012,
3,
1021.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Small- and intermediate-conductance Ca(2+)-activated potassium channels,
activated by Ca(2+)-bound calmodulin, have an important role in regulating
membrane excitability. These channels are also linked to clinical abnormalities.
A tremendous amount of effort has been devoted to developing small molecule
compounds targeting these channels. However, these compounds often suffer from
low potency and lack of selectivity, hindering their potential for clinical use.
A key contributing factor is the lack of knowledge of the binding site(s) for
these compounds. Here we demonstrate by X-ray crystallography that the binding
pocket for the compounds of the 1-ethyl-2-benzimidazolinone (1-EBIO) class is
located at the calmodulin-channel interface. We show that, based on structure
data and molecular docking, mutations of the channel can effectively change the
potency of these compounds. Our results provide insight into the molecular
nature of the binding pocket and its contribution to the potency and selectivity
of the compounds of the 1-EBIO class.
|
 |
|
|
|
|
 |